Bristol-Myers Squibb
This article was originally published in The Tan Sheet
Executive Summary
Sales of Boost adult nutritional supplement increase 16% to $23 mil. in the first quarter, BMS announces April 21. Overall nutritional sales were flat at $449 mil. "as domestic sales growth of 6% was offset by the adverse effects of the economic downturn in Asian markets," the firm notes. Infant formula sales rose 3% to $318 mil., and Enfamil, Bristol's best-selling formula brand, had a 5% sales increase to $179 mil. Specialty infant formula sales were flat at $11 mil., including Nutramigen, which had an 11% sales rise to $32 mil
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning